NASDAQ:INM

Inmed Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy INM

*Your capital is at risk

$1.47

-0.0300 (-2.00%)

At Close: Jul 31, 2026

Inmed Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 1.48M and sold 5.98K INM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	1.48M shares
● Sell	5.98K shares
80% Buy Activity Strong Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 16, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	19 Value: $29
Jul 16, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	2 Value: $3
Jul 15, 2026 Buy	Common Shares P-Purchase	Adar1 Capital Management, Llc 10 Percent Owner	10% Owner	1 000 Value: $2K
Jul 15, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	13 761 Value: $21.3K
Jul 15, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	1 389 Value: $2K
Jul 14, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	493 Value: $764
Jul 14, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	4 882 Value: $8K
Jul 02, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	1 460 Value: $2K
Jul 02, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	147 Value: $228
Jul 01, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	3 946 Value: $6K
Jul 01, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	398 Value: $617
Jun 30, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	545 Value: $839
Jun 30, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	55 Value: $85
Jun 08, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	2 982 Value: $5K
Jun 08, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	29 518 Value: $44.9K
Jun 05, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	5 045 Value: $8K
Jun 05, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	49 966 Value: $78.4K
Jun 04, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	6 125 Value: $10K
Jun 04, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	618 Value: $970
Jun 03, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	7 069 Value: $11.0K
Jun 03, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	714 Value: $1K
Jun 02, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	20 753 Value: $31.5K
Jun 02, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	2 095 Value: $3K
Jun 01, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	1 498 Value: $2K
Jun 01, 2026 Buy	Common Shares P-Purchase	Vivo Opportunity, Llc 10 Percent Owner	10% Owner	14 838 Value: $23.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT INMED PHARMACEUTICALS INC.

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it en...

Read Full Profile Here